Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The impact of obesity on follow-up after an abnormal screening mammogram.

Schur EA, Elmore JE, Onega T, Wernli KJ, Sickles EA, Haneuse S.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):327-36. doi: 10.1158/1055-9965.EPI-11-0762. Epub 2011 Dec 5.

2.

Frequency and predictive value of a mammographic recommendation for short-interval follow-up.

Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL.

J Natl Cancer Inst. 2003 Mar 19;95(6):429-36.

3.

Timeliness of follow-up after abnormal screening mammogram: variability of facilities.

Rosenberg RD, Haneuse SJ, Geller BM, Buist DS, Miglioretti DL, Brenner RJ, Smith-Bindman R, Taplin SH; Breast Cancer Surveillance Consortium.

Radiology. 2011 Nov;261(2):404-13. doi: 10.1148/radiol.11102472. Epub 2011 Sep 7.

4.

Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.

Kerlikowske K, Smith-Bindman R, Abraham LA, Lehman CD, Yankaskas BC, Ballard-Barbash R, Barlow WE, Voeks JH, Geller BM, Carney PA, Sickles EA.

Radiology. 2005 Mar;234(3):684-92.

PMID:
15734926
5.

Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.

Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL; Breast Cancer Surveillance Consortium.

J Gen Intern Med. 2013 Nov;28(11):1454-62. doi: 10.1007/s11606-013-2507-0. Epub 2013 Jun 13.

6.

Timing of follow-up after abnormal screening and diagnostic mammograms.

Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS.

Am J Manag Care. 2011 Feb;17(2):162-7.

7.

Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.

Goldman LE, Walker R, Hubbard R, Kerlikowske K; Breast Cancer Surveillance Consortium.

Med Care. 2013 Apr;51(4):307-14. doi: 10.1097/MLR.0b013e318280f04c.

8.

'Weighing in' on screening mammography.

Berz D, Sikov W, Colvin G, Weitzen S.

Breast Cancer Res Treat. 2009 Apr;114(3):569-74. doi: 10.1007/s10549-008-0037-y. Epub 2008 May 20.

PMID:
18491226
9.

Obesity and breast cancer screening.

Wee CC, McCarthy EP, Davis RB, Phillips RS.

J Gen Intern Med. 2004 Apr;19(4):324-31.

10.

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A.

Breast Cancer Res Treat. 2013 Apr;138(3):879-87. doi: 10.1007/s10549-013-2466-5. Epub 2013 Mar 8.

11.

Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?

Mouchawar J, Taplin S, Ichikawa L, Barlow WE, Geiger AM, Weinmann S, Gilbert J, Manos MM, Ulcickas Yood M.

J Natl Cancer Inst Monogr. 2005;(35):39-46.

PMID:
16287884
12.

Obesity, mammography use and accuracy, and advanced breast cancer risk.

Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS.

J Natl Cancer Inst. 2008 Dec 3;100(23):1724-33. doi: 10.1093/jnci/djn388. Epub 2008 Nov 25.

13.

Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States).

Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, Lee NC.

Cancer Causes Control. 2006 Feb;17(1):29-38.

PMID:
16411050
14.

What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.

Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):723-32.

15.

Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.

Carney PA, Abraham LA, Miglioretti DL, Yabroff KR, Sickles EA, Buist DS, Kasales CJ, Geller BM, Rosenberg RD, Dignan MB, Weaver DL, Kerlikowske K; Breast Cancer Surveillance Consortium.

AJR Am J Roentgenol. 2007 Feb;188(2):385-92.

PMID:
17242246
16.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K.

Breast Cancer Res. 2015 Jan 8;17:1. doi: 10.1186/s13058-014-0509-4.

17.

The association between obesity and screening mammography accuracy.

Elmore JG, Carney PA, Abraham LA, Barlow WE, Egger JR, Fosse JS, Cutter GR, Hendrick RE, D'Orsi CJ, Paliwal P, Taplin SH.

Arch Intern Med. 2004 May 24;164(10):1140-7.

18.

Comparing the performance of mammography screening in the USA and the UK.

Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K.

J Med Screen. 2005;12(1):50-4.

PMID:
15814020
19.

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE.

J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. doi: 10.1093/jnci/djq233. Epub 2010 Jul 2.

20.

Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.

White A, Miller J, Royalty J, Ryerson AB, Benard V, Helsel W, Kammerer W.

Cancer Causes Control. 2015 May;26(5):723-32. doi: 10.1007/s10552-015-0567-7. Epub 2015 Mar 26.

Items per page

Supplemental Content

Write to the Help Desk